HGF and breast carcinoma: Moreover, the inhibition of α9, α2β1, and α3β1 integrins with relevant specific blocking antibodies significantly reduced HGF-induced migration of lymphocytic endothelial cells and breast carcinoma cells (Beviglia and Kramer, 1999; Kajiya et al., 2005).